Previously, robust indicators for the prognosis of decompensation included clinical parameters combined with quantitative measures such as CPS, which includes components such as albumin, bilirubin, ascites, encephalopathy, and prothrombin time, and the measurement of hepatic vein pressure gradient with MELD score [21,22]. This evidence concerns the gene F2 and Ascites.